AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglyn M 50/1000 Tablet SR

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaglyn M 50/1000 Tablet SR

Diabex Duo 50/1000 SR tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like renal failure and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo 50/1000 SR may be used independently or with other antidiabetic drugs, and its efficacy is enhanced by a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Taking it with food minimizes gastrointestinal upset. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Adherence to your doctor's dietary and exercise plan is crucial for optimal diabetes control; lifestyle choices significantly impact management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia, a potential side effect, especially when combined with insulin or sulfonylureas, requires awareness and appropriate management strategies. This medication isn't suitable for everyone. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating individuals should also seek medical counsel. Interactions with other medications are possible; therefore, disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Sitaglyn M 50/1000 Tablet SR

Managing type 2 diabetes

Major Benefits of Sitaglyn M 50/1000 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Sitaglyn M 50/1000 Tablet SR whole; do not chew, crush, or fracture it. Administer this medication with a meal.

Common Side effects of Sitaglyn M 50/1000 Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglyn M 50/1000 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take Sitaglyn M 50/1000 Tablet SR with a meal.

How Sitaglyn M 50/1000 Tablet SR works:

Sitaglyn M 50/1000 SR tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglyn M 50/1000 SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaglyn M 50/1000 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Sitaglyn M 50/1000 tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglyn M 50/1000 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitaglyn M 50/1000 SR tablet use. Physician consultation is necessary. Kidney function should be regularly monitored during treatment with this medication.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitaglyn M 50/1000 SR tablets; their use may be unsafe. Medical advice is recommended.

What if you forget to take Sitaglyn M 50/1000 Tablet SR :

Should you forget to take a Sitaglyn M 50/1000 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglyn M 50/1000 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitaglyn M 50/1000 Tablet SR

Sitaglyn M 50/1000 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaglyn M 50/1000 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), and balance problems. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaglyn M 50/1000 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaglyn M 50/1000 Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaglyn M 50/1000 Tablet SR and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Sitaglyn M 50/1000 Tablet SR) can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaglyn M 50/1000 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 50/1000 SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaglyn M 50/1000 Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M 50/1000 SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 50/1000 Tablet SR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglyn M 50/1000 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaglyn M 50/1000 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 50/1000 SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaglyn M 50/1000 Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M 50/1000 Tablet SR with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 50/1000 Tablet SR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglyn M 50/1000 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglyn M 50/1000 Tablet...
143